封面
市场调查报告书
商品编码
1547994

全球合法大麻市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Legal Marijuana Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

全球合法大麻市场需求预计将从 2023 年的 207.8 亿美元达到近 1,499.9 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 24.56%。

一些国家已将出于医疗和娱乐目的持有、分配、种植和消费大麻合法化。而且,在大多数国家,这些政策均受《联合国麻醉药品单一公约》监管。大麻在市场上有多种形式:花蕾、油和酊剂。这种精神活性药物的医学应用会导致慢性疼痛、精神障碍、癌症和其他神经系统疾病。大麻的成人用途包括用作食品成分和精神药物。

市场动态

随着医疗和成人用途的合法大麻使用量激增,全球对其的需求预计将大幅增加。此外,对疼痛管理治疗的需求不断增长,加上老年族群慢性疼痛负担的增加,预计将提高产品需求。然而,COVID-19大流行对消费者的购买能力和无缝贸易施加了一些限制。这是合法大麻市场面临的主要挑战。另一方面,大麻在治疗多种疾病、癌症、焦虑症、帕金森氏症和阿兹海默症方面的应用范围预计将预示着产品在全球市场的渗透。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球合法大麻市场的每个细分市场进行了包容性评估。合法大麻产业的成长和趋势为本研究提供了整体方法。

市场区隔

合法大麻市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按申请

  • 医疗(慢性疼痛、癌症、忧郁和焦虑、关节炎、糖尿病、青光眼、偏头痛、癫痫、多发性硬化症、爱滋病、肌萎缩侧索硬化症、阿兹海默症、创伤后压力症候群( PTSD)、巴金森氏症、妥瑞氏症等)
  • 成人使用

依产品类型

  • 油和酊剂

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲合法大麻市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。合法大麻市场的主要参与者包括顶篷 Growth Corporation、Aurora Cannabis Inc.、Tilray Brands Inc. (Aphria Inc.)、Abcann Medicinals Inc. (Vivo Cannabis Inc.)、The Cronos Group、Maricann Inc.、 Organigram Holdings Inc. .、Lexaria Bioscience、Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.)、Tikun Olam、United Cannabis Corporation。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:合法大麻 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析:依应用分类
    • 市场吸引力分析:按产品类型
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球合法大麻市场分析:按应用分类

  • 概述:按应用
  • 历史和预测数据
  • 分析:按应用
  • 医疗(慢性疼痛、癌症、忧郁和焦虑、关节炎、糖尿病、青光眼、偏头痛、癫痫、多发性硬化症、爱滋病、肌萎缩侧索硬化症、阿兹海默症、创伤后压力症候群( PTSD)、帕金森氏症、抽动秽语等)
  • 成人使用

第 6 章:全球合法大麻市场分析:按产品类型

  • 概述:按产品类型
  • 历史和预测数据
  • 分析:依产品类型
  • 油和酊剂

第 7 章:全球合法大麻市场分析:按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:合法大麻公司的竞争格局

  • 合法大麻市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Canopy Growth Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Aurora Cannabis Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Tilray Brands Inc. (Aphria Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Abcann Medicinals Inc. (Vivo Cannabis Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • The Cronos Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Maricann Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Organigram Holdings Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Lexaria Bioscience
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Tikun Olam
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • United Cannabis Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11212091

The global demand for Legal Marijuana Market is presumed to reach the market size of nearly USD 149.99 Billion by 2032 from USD 20.78 Billion in 2023 with a CAGR of 24.56% under the study period 2024-2032.

Several countries have legalized possession, distribution, cultivation, and consumption of marijuana for medical and recreational purposes. And, in most nations, these policies are regulated by the United Nations Single Convention on Narcotic Drugs. Marijuana is available in several forms in the market, buds, oil, and tinctures. The medical application of this psychoactive drug is subjected to chronic pain, mental disorders, cancer, and other neurological diseases. The Adult-use of marijuana can range from being used as a food ingredient to a psychoactive drug.

MARKET DYNAMICS

With the soar in the use of legal marijuana for medical and adult-use, the global demands for the same are anticipated to grow significantly. Moreover, the growing need for pain management treatments along with the rising burden of chronic pain among the geriatric population is anticipated to lift the product demand. However, the COVID-19 pandemic has imposed several restrictions in terms of the buying capability of consumers and seamless trade. This acts as a key challenge for the legal marijuana market. On the other side, the scope of marijuana in treating several ailments, cancer, anxiety, and Parkinson's and Alzheimer's disease is anticipated to bode well for product penetration in the global market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Legal Marijuana. The growth and trends of Legal Marijuana industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Legal Marijuana market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Medical (Chronic Pain, Cancer, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer's, Post-traumatic Stress Disorder (PTSD), Parkinson's, Tourette's, Others)
  • Adult Use

By Product Type

  • Flower
  • Oil & Tinctures

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Legal Marijuana market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Legal Marijuana market include Canopy Growth Corporation, Aurora Cannabis Inc., Tilray Brands Inc. (Aphria Inc.), Abcann Medicinals Inc. (Vivo Cannabis Inc.), The Cronos Group, Maricann Inc., Organigram Holdings Inc., Lexaria Bioscience, Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.), Tikun Olam, United Cannabis Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. LEGAL MARIJUANA - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Product Type
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL LEGAL MARIJUANA MARKET ANALYSIS BY APPLICATION

  • 5.1. Overview By Application
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Application
  • 5.4. Medical (Chronic Pain, Cancer, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer's, Post-traumatic Stress Disorder (PTSD), Parkinson's, Tourette's, Others) Historic and Forecast Sales By Regions
  • 5.5. Adult Use Historic and Forecast Sales By Regions

6. GLOBAL LEGAL MARIJUANA MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1. Overview By Product Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Product Type
  • 6.4. Flower Historic and Forecast Sales By Regions
  • 6.5. Oil & Tinctures Historic and Forecast Sales By Regions

7. GLOBAL LEGAL MARIJUANA MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE LEGAL MARIJUANA COMPANIES

  • 8.1. Legal Marijuana Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF LEGAL MARIJUANA INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Canopy Growth Corporation
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Aurora Cannabis Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Tilray Brands Inc. (Aphria Inc.)
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Abcann Medicinals Inc. (Vivo Cannabis Inc.)
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. The Cronos Group
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Maricann Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Organigram Holdings Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Lexaria Bioscience
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.)
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Tikun Olam
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. United Cannabis Corporation
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Application (USD MN)
  • Medical (Chronic Pain, Cancer, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer's, Post-traumatic Stress Disorder (PTSD), Parkinson's, Tourette's, Others) Market Sales By Geography (USD MN)
  • Adult Use Market Sales By Geography (USD MN)
  • Analysis By Product Type (USD MN)
  • Flower Market Sales By Geography (USD MN)
  • Oil & Tinctures Market Sales By Geography (USD MN)
  • Global Legal Marijuana Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Legal Marijuana Report
  • Market Research Process
  • Market Research Methodology
  • Global Legal Marijuana Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Application (USD MN)
  • Medical (Chronic Pain, Cancer, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer's, Post-traumatic Stress Disorder (PTSD), Parkinson's, Tourette's, Others) Market Sales By Geography (USD MN)
  • Adult Use Market Sales By Geography (USD MN)
  • Global Market Analysis By Product Type (USD MN)
  • Flower Market Sales By Geography (USD MN)
  • Oil & Tinctures Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.